Transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the Western Cape Province, South Africa.

Antitubercular Agents / pharmacology Drug Resistance Extensively Drug-Resistant Tuberculosis / epidemiology Fluoroquinolones / pharmacology Humans Mutation Rifampin South Africa / epidemiology
XDR-TB drug resistance transmission tuberculosis whole genome sequencing

Journal

Microbial genomics
ISSN: 2057-5858
Titre abrégé: Microb Genom
Pays: England
ID NLM: 101671820

Informations de publication

Date de publication:
04 2022
Historique:
entrez: 26 4 2022
pubmed: 27 4 2022
medline: 29 4 2022
Statut: ppublish

Résumé

Extensively drug-resistant tuberculosis (XDR-TB), defined as resistance to at least isoniazid (INH), rifampicin (RIF), a fluoroquinolone (FQ) and a second-line injectable drug (SLID), is difficult to treat and poses a major threat to TB control. The transmission dynamics and distribution of XDR

Identifiants

DOI: 10.1099/mgen.0.000815 PMID: 35471145 PMC: PMC9453078
pubmed: 35471145
doi: 10.1099/mgen.0.000815
pmc: PMC9453078
doi:

Substances chimiques

Antitubercular Agents 0
Fluoroquinolones 0
Rifampin VJT6J7R4TR

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S03563X/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : MR/S027777/1
Pays : United Kingdom

Références

Zhonghua Jie He He Hu Xi Za Zhi. 2018 Mar 12;41(3):207-212
pubmed: 29518850
J Clin Microbiol. 2019 Jan 2;57(1):
pubmed: 30404943
Clin Microbiol Infect. 2018 Aug;24(8):889-895
pubmed: 29175351
Clin Infect Dis. 2020 May 23;70(11):2396-2402
pubmed: 31342067
Sci Rep. 2019 Apr 3;9(1):5602
pubmed: 30944370
PLoS One. 2017 Oct 13;12(10):e0181797
pubmed: 29028800
Microb Genom. 2018 Feb;4(2):
pubmed: 29310751
J Genet. 2017 Sep;96(4):599-612
pubmed: 28947708
Nat Rev Microbiol. 2019 Sep;17(9):533-545
pubmed: 31209399
EBioMedicine. 2018 Nov;37:410-416
pubmed: 30341041
J Infect Dis. 1999 Nov;180(5):1608-15
pubmed: 10515823
Genome Med. 2015 May 27;7(1):51
pubmed: 26019726
Lancet. 2006 Nov 4;368(9547):1575-80
pubmed: 17084757
Int J Tuberc Lung Dis. 2008 Jan;12(1):99-104
pubmed: 18173885
Mol Phylogenet Evol. 2019 Mar;132:46-52
pubmed: 30513341
PLoS One. 2012;7(8):e42323
pubmed: 22912700
Microb Genom. 2021 Nov;7(11):
pubmed: 34793294
Microbes Infect. 2010 Jun;12(6):467-75
pubmed: 20215000
Nat Genet. 2013 Jul;45(7):784-90
pubmed: 23749189
Lancet Infect Dis. 2013 Feb;13(2):137-46
pubmed: 23158499
PLoS Med. 2007 Jan;4(1):e50
pubmed: 17253901
PLoS One. 2011;6(9):e25075
pubmed: 21949856
Lancet. 1995 May 6;345(8958):1148-50
pubmed: 7723548
J Glob Antimicrob Resist. 2021 Mar;24:6-13
pubmed: 33279682
Nat Genet. 2014 Mar;46(3):279-86
pubmed: 24464101
Antimicrob Agents Chemother. 2002 May;46(5):1204-11
pubmed: 11959546
S Afr Med J. 2017 Nov 27;107(12):1078-1081
pubmed: 29262960
PLoS Med. 2015 Sep 29;12(9):e1001880
pubmed: 26418737
Int J Tuberc Lung Dis. 2013 Oct;17(10):1322-7
pubmed: 24025385
Int J Tuberc Lung Dis. 2019 Jun 1;23(6):720-727
pubmed: 31315705
N Engl J Med. 2017 Jan 19;376(3):243-253
pubmed: 28099825
PLoS One. 2020 Apr 24;15(4):e0224908
pubmed: 32330146
Tuberculosis (Edinb). 2015 Jun;95 Suppl 1:S177-89
pubmed: 25797613
BMC Med. 2020 Feb 4;18(1):24
pubmed: 32014024
Nucleic Acids Res. 2019 Jul 2;47(W1):W256-W259
pubmed: 30931475
J Infect Dis. 2017 Nov 3;216(suppl_6):S629-S635
pubmed: 29112747
Nat Genet. 2016 Dec;48(12):1535-1543
pubmed: 27798628
Epidemics. 2016 Mar;14:54-61
pubmed: 26972514
J Clin Microbiol. 2013 Jun;51(6):1818-25
pubmed: 23554196
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Mol Microbiol. 2010 Aug;77(4):830-40
pubmed: 20545852
Antimicrob Agents Chemother. 2013 Feb;57(2):827-32
pubmed: 23208709
Genome Med. 2019 Jun 24;11(1):41
pubmed: 31234910
J Infect. 2018 Jan;76(1):55-67
pubmed: 29031637
J Infect. 2016 Sep;73(3):210-8
pubmed: 27311749
J Clin Microbiol. 2014 Oct;52(10):3795-8
pubmed: 25078914
Antimicrob Agents Chemother. 1999 Aug;43(8):1866-9
pubmed: 10428904
Crit Rev Anal Chem. 2017 Jul 4;47(4):298-308
pubmed: 28080136
Tuberculosis (Edinb). 2009 Mar;89(2):120-5
pubmed: 19054717
Int J Infect Dis. 2010 Oct;14(10):e828-37
pubmed: 20570541
J Infect Dis. 1994 Jul;170(1):151-6
pubmed: 8014491
Sci Rep. 2020 Feb 13;10(1):2600
pubmed: 32054988
PLoS One. 2020 Apr 21;15(4):e0231637
pubmed: 32315335
Nat Med. 1998 Dec;4(12):1343-4
pubmed: 9846553
Int J Infect Dis. 2017 Mar;56:14-20
pubmed: 28163165
Science. 2006 Sep 15;313(5793):1554
pubmed: 16973846
Eur Respir J. 2018 Jun 21;51(6):
pubmed: 29748309
Emerg Infect Dis. 2006 May;12(5):736-43
pubmed: 16704829

Auteurs

Selien Oostvogels (S)

Family Medicine and Population Health (FAMPOP), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.

Serej D Ley (SD)

DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Stellenbosch University, Cape Town, South Africa.
Present address: Sefunda AG, Muttenz, Switzerland.

Tim H Heupink (TH)

Family Medicine and Population Health (FAMPOP), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.

Anzaan Dippenaar (A)

Family Medicine and Population Health (FAMPOP), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Unit of Mycobacteriology, Institute of Tropical Medicine, Antwerp, Belgium.

Elizabeth M Streicher (EM)

DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Stellenbosch University, Cape Town, South Africa.

Elise De Vos (E)

Family Medicine and Population Health (FAMPOP), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.

Conor J Meehan (CJ)

Unit of Mycobacteriology, Institute of Tropical Medicine, Antwerp, Belgium.
Department of Biosciences, Nottingham Trent University, Nottingham, UK.

Keertan Dheda (K)

Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute, South Africa.
South African MRC Centre for the Study of Antimicrobial Resistance, University of Cape Town, Cape Town, South Africa.
Faculty of Infectious and Tropical Diseases, Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, UK.

Rob Warren (R)

DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Stellenbosch University, Cape Town, South Africa.

Annelies Van Rie (A)

Family Medicine and Population Health (FAMPOP), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Antituberculeux › Transmission, distribution and drug...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Transmission, distribution and drug...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram positif › Infections à Actinomycetales › Infections à Mycobacterium › Tuberculose › Tuberculose multirésistante › Tuberculose ultrarésistante aux médicaments › Transmission, distribution and drug...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › Quinoléines › Quinolinone › Fluoroquinolones › Transmission, distribution and drug...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Transmission, distribution and drug...
questionsmedicales.fr › Phénomènes génétiques › Variation génétique › Mutation › Transmission, distribution and drug...
questionsmedicales.fr › Composés polycycliques › Composés macrocycliques › Lactames macrocycliques › Rifamycine › Rifampicine › Transmission, distribution and drug...
questionsmedicales.fr › Régions géographiques › Afrique › Afrique subsaharienne › Afrique australe › République d'Afrique du Sud › Transmission, distribution and drug...